Table 4.

Association of Habitual Snoring (Habitual snoring vs. No Habitual snoring) with Cardiovascular Outcomes and All-cause Mortality in MESA^*

Outcome	# of events	Univariate Hazard ratio(95%CI)	P value	Multivariate Hazard ratio(95%CI)	P value
Composite	310	0.85(0.65 – 1.11)	0.23	0.91(0.69–1.20)	0.49
Hard CHD	128	0.77(0.51– 1.18)	0.23	0.89(0.57– 1.40)	0.63
MI	107	0.75(0.47– 1.19)	0.22	0.87(0.53– 1.42)	0.58
Angina	180	0.89(0.63–1.26)	0.51	0.96(0.63–1.32	0.60
Stroke	76	1.09(0.66–1.79)	0.74	1.24(0.73–2.13)	0.42
All-cause mortality	189	0.87(0.62–1.23)	0.43	1.17(0.81 –1.68)	0.40

Multivariable model were adjusted for age, gender, race/ethnicity, BMI, cigarette smoking, diabetes mellitus, total cholesterol, HDL, triglycerides, systolic blood pressure, BP medication use, statin use, benzodiazepine use and current alcohol use.

^*Participants reporting snoring >3–5 days/ week compared to those reporting no snoring or snoring < 3–5days/week.